Combination Chemotherapy in Treating Women With Stage III Breast Cancer
Breast Cancer
About this trial
This is an interventional treatment trial for Breast Cancer focused on measuring stage IIIA breast cancer, stage IIIB breast cancer, stage IIIC breast cancer
Eligibility Criteria
DISEASE CHARACTERISTICS: Histologically confirmed stage III breast cancer Measurable disease No inflammatory breast cancer No synchronous bilateral breast cancer Hormone receptor status: Not specified PATIENT CHARACTERISTICS: Age: 21 to 75 Sex: Female Menopausal status: Not specified Performance status: ECOG 0-1 OR Zubrod 0-1 Life expectancy: More than 12 weeks Hematopoietic: WBC greater than 4,000/mm^3 Platelet count greater than 100,000/mm^3 Hepatic: Bilirubin less than 1.25 times upper limit of normal (ULN) AST less than 1.25 times ULN Renal: Creatinine clearance greater than 70 mL/min Cardiovascular: No angina pectoris No significant arrhythmia requiring therapy No bilateral bundle branch block No congestive heart failure No myocardial infarction Other: No medical or psychiatric disease that would preclude study therapy No other malignancy except adequately treated nonmelanomatous skin cancer or carcinoma in situ of the cervix Not pregnant PRIOR CONCURRENT THERAPY: Biologic therapy: Not specified Chemotherapy: Not specified Endocrine therapy: Not specified Radiotherapy: No prior radiotherapy Surgery: No prior surgery except incisional biopsy or fine-needle aspiration Other: No prior systemic therapy No concurrent caffeine or alcohol
Sites / Locations
- Policlinica Privada Instituto De Medicina Nuclear
- Consultorio Oncologico Privado
- Centro De Oncologia y Terapia Radiante
- Unidad Oncologica Del Comahue
- Consultorio Oncologico Privado
- Centro Oncologico Del Litoral
- Centro Oncologico Tres Arroyos